First- and second- phase insulin secretion are impaired in type 2 diabetes and under hyperglycemic glucose clamp conditions, endogenous GLP-1 is reported to augment both phases of insulin secretion in response to duodenal nutrition perfusion [13]. The gene discussed is INS; the disease is type 2 diabetes mellitus.